Market closed

Crinetics Pharmaceuticals/CRNX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Crinetics Pharmaceuticals

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Ticker

CRNX
Trading on

Industry

Biotechnology

Employees

290

CRNX Metrics

BasicAdvanced
$4.3B
Market cap
-
P/E ratio
-$3.75
EPS
0.68
Beta
-
Dividend rate
$4.3B
0.68
$55.78
$25.75
610K
16.087
15.961
5.522
6.418
-28.27%
-47.66%
2,642.466
5.07
5.07
-19.777
-71.35%
10.16%
12.76%

What the Analysts think about CRNX

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Crinetics Pharmaceuticals stock.

CRNX Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CRNX Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy CRNX

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Crinetics Pharmaceuticals stock?

Crinetics Pharmaceuticals (CRNX) has a market cap of $4.3B as of October 08, 2024.

What is the P/E ratio for Crinetics Pharmaceuticals stock?

The price to earnings (P/E) ratio for Crinetics Pharmaceuticals (CRNX) stock is 0 as of October 08, 2024.

Does Crinetics Pharmaceuticals stock pay dividends?

No, Crinetics Pharmaceuticals (CRNX) stock does not pay dividends to its shareholders as of October 08, 2024.

When is the next Crinetics Pharmaceuticals dividend payment date?

Crinetics Pharmaceuticals (CRNX) stock does not pay dividends to its shareholders.

What is the beta indicator for Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals (CRNX) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.